2.73
price down icon1.44%   -0.04
after-market 시간 외 거래: 2.69 -0.04 -1.47%
loading
전일 마감가:
$2.77
열려 있는:
$2.77
하루 거래량:
138.82K
Relative Volume:
0.32
시가총액:
$214.46M
수익:
-
순이익/손실:
$-29.07M
주가수익비율:
-8.8065
EPS:
-0.31
순현금흐름:
$-31.85M
1주 성능:
-4.55%
1개월 성능:
-18.51%
6개월 성능:
+0.00%
1년 성능:
+111.63%
1일 변동 폭
Value
$2.73
$2.83
1주일 범위
Value
$2.67
$3.07
52주 변동 폭
Value
$0.97
$4.00

트레비 테라퓨틱스 Stock (TRVI) Company Profile

Name
명칭
Trevi Therapeutics Inc
Name
전화
203-304-2499
Name
주소
195 CHURCH STREET, NEW HAVEN, CT
Name
직원
27
Name
트위터
@TreviThera
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
TRVI's Discussions on Twitter

TRVI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
TRVI 2.73 214.46M 0 -29.07M -31.85M -0.31
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

트레비 테라퓨틱스 Stock (TRVI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-04-12 개시 B. Riley Securities Buy
2022-11-22 개시 SVB Leerink Outperform
2019-06-03 개시 BMO Capital Markets Outperform
2019-06-03 개시 Needham Buy
2019-06-03 개시 SVB Leerink Outperform
2019-06-03 개시 Stifel Buy
모두보기

트레비 테라퓨틱스 주식(TRVI)의 최신 뉴스

pulisher
07:30 AM

Trevi Therapeutics to Present Haduvio Development at Piper Sandler Healthcare Conference | TRVI Stock News - StockTitan

07:30 AM
pulisher
Nov 16, 2024

Trevi Therapeutics to Participate in Upcoming April Events - GuruFocus.com

Nov 16, 2024
pulisher
Nov 16, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives $7.43 Consensus Target Price from Brokerages - Defense World

Nov 16, 2024
pulisher
Nov 14, 2024

Trevi Therapeutics to Present at the Emerging Growth Conference on February 22, 2023 - Quantisnow

Nov 14, 2024
pulisher
Nov 13, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives $7.43 Average PT from Brokerages - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

How Do Things Look For Trevi Therapeutics Inc (NASDAQ: TRVI) In The Short-Term? - Stocks Register

Nov 12, 2024
pulisher
Nov 12, 2024

Trevi Therapeutics Announces Proposed Public Offering - Quantisnow

Nov 12, 2024
pulisher
Nov 12, 2024

Trevi Therapeutics to Participate in Upcoming September Events - Quantisnow

Nov 12, 2024
pulisher
Nov 12, 2024

Trevi Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference - Quantisnow

Nov 12, 2024
pulisher
Nov 12, 2024

Trevi Therapeutics Provides Business Update Ahead of Upcoming Conferences - Quantisnow

Nov 12, 2024
pulisher
Nov 11, 2024

FY2024 Earnings Forecast for TRVI Issued By Leerink Partnrs - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Leerink Partnrs Has Negative Outlook of TRVI FY2024 Earnings - Defense World

Nov 11, 2024
pulisher
Nov 08, 2024

Earnings call: Trevi Therapeutics reports Q3 2024 financials, clinical updates - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Trevi Therapeutics' (TRVI) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings call: Trevi Therapeutics reports Q3 2024 financials, clinical updates By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 07, 2024

Trevi Therapeutics Inc (TRVI) Q3 2024 Earnings Call Highlights: - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Trevi Therapeutics Inc (TRVI) Q3 2024 Earnings Call Highlights: Navigating Increased Losses and ... - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Trevi Therapeutics Reports Q3 2024 Progress and Financials - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Trevi Therapeutics Advances Clinical Trials Despite Widening Q3 Losses; Cash Runway Extended | TRVI Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Rosalind Advisors Inc. Sells 641,577 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) - MarketBeat

Nov 06, 2024
pulisher
Nov 04, 2024

Trevi Therapeutics to Report Third Quarter 2024 Financial Result - GuruFocus.com

Nov 04, 2024
pulisher
Oct 31, 2024

Trevi Therapeutics (TRVI) Set to Announce Earnings on Wednesday - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024 - StreetInsider.com

Oct 30, 2024
pulisher
Oct 30, 2024

Trevi Therapeutics Adds Clinical Development Expertise in Chroni - GuruFocus.com

Oct 30, 2024
pulisher
Oct 23, 2024

Rosalind Advisors, Inc. Reduces Stake in Trevi Therapeutics Inc. - Yahoo Finance UK

Oct 23, 2024
pulisher
Oct 22, 2024

Trevi Therapeutics shares retain buy rating on Haduvio prospects By Investing.com - Investing.com UK

Oct 22, 2024
pulisher
Oct 22, 2024

Trevi Therapeutics (NASDAQ:TRVI) Given "Buy" Rating at HC Wainwright - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

Trevi Therapeutics completes enrollment for Phase 2a trial - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

Trevi Therapeutics completes enrollment for Phase 2a trial By Investing.com - Investing.com Australia

Oct 21, 2024
pulisher
Oct 21, 2024

Trevi Therapeutics, Inc. Completes Enrollment in the Phase 2A RIVER Trial of Haduvio - Marketscreener.com

Oct 21, 2024
pulisher
Oct 21, 2024

Trevi Therapeutics Completes Enrollment for Phase 2a RIVER Trial in Refractory Chronic Cough - Citizentribune

Oct 21, 2024
pulisher
Oct 19, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Oct 19, 2024
pulisher
Oct 18, 2024

TSX Global Gold Index (TTGD) QuotePress Release - The Globe and Mail

Oct 18, 2024
pulisher
Oct 15, 2024

Trevi Therapeutics to Participate in Upcoming Commercial and Investor Conferences - Citizentribune

Oct 15, 2024
pulisher
Oct 09, 2024

Trevi Therapeutics Inc (TRVI) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Trevi Therapeutics Inc (TRVI) Q2 2024 Earnings Call Highlights: - GuruFocus.com

Oct 09, 2024
pulisher
Oct 08, 2024

Oppenheimer maintains Outperform on Trevi Therapeutics on Haduvio potential By Investing.com - Investing.com Canada

Oct 08, 2024
pulisher
Oct 07, 2024

Trevi Therapeutics' (TRVI) Buy Rating Reaffirmed at B. Riley - MarketBeat

Oct 07, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics reports progress in clinical trials - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics (NASDAQ:TRVI) Given "Buy" Rating at Needham & Company LLC - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi updates on clinical progress for chronic cough treatment - The Pharma Letter

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics reports progress in clinical trials By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics, Inc. Announces Updates on Its Clinical Development Programs - Marketscreener.com

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics shares keep buy rating, positive trials By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics hits 50% enrollment in IPF cough study By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 03, 2024

Trevi Therapeutics hits 50% enrollment in IPF cough study - Investing.com India

Oct 03, 2024

트레비 테라퓨틱스 (TRVI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

트레비 테라퓨틱스 주식 (TRVI) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
GOOD JENNIFER L
President & CEO
Sep 09 '24
Option Exercise
1.43
1,840
2,631
215,153
GOOD JENNIFER L
President & CEO
Sep 06 '24
Sale
3.03
4,219
12,784
213,313
GOOD JENNIFER L
President & CEO
Sep 09 '24
Sale
3.04
1,840
5,587
213,313
GOOD JENNIFER L
President & CEO
Sep 05 '24
Option Exercise
1.43
40,277
57,596
253,590
GOOD JENNIFER L
President & CEO
Sep 04 '24
Option Exercise
1.43
10,981
15,703
224,294
GOOD JENNIFER L
President & CEO
Sep 03 '24
Option Exercise
1.43
3,863
5,524
217,176
GOOD JENNIFER L
President & CEO
Sep 05 '24
Sale
3.11
40,277
125,310
213,313
GOOD JENNIFER L
President & CEO
Sep 04 '24
Sale
3.02
10,981
33,205
213,313
GOOD JENNIFER L
President & CEO
Sep 03 '24
Sale
3.02
3,863
11,677
213,313
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):